Nonclinical Safety Pharmacology Study of the Herbal Product HAD-B1
HAD-B1 is a Korean herbal formula designed to treat solid tumors, and through cell experiments, it has proven to have an anticancer effect. The current study aims to test the safety of HAD-B1. This experiment is under the regulation of ICH. In order to find if HAD-B1 has any effect on the CNS, 0, 50...
Guardado en:
Autores principales: | Soo-Dam Kim, Jae-Ho Yang, Eun-Bin Kwag, Ji-Hye Park, So-Jung Park, Hwa-Seung Yoo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3aa9d6a638064f50a1c591ce8fa13361 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacological Effects of Centella asiatica on Skin Diseases: Evidence and Possible Mechanisms
por: Kyoung Sik Park
Publicado: (2021) -
Study of the Therapeutic Effects of Chinese Herbal Decoction Combined with Glucocorticoid in Treating Primary Nephrotic Syndrome in Children
por: Xue Hou, et al.
Publicado: (2021) -
Development of the 8-Item Phlegm Pattern Questionnaire (PPQ-8) Using Rasch Analysis
por: Young-Jae Park
Publicado: (2021) -
Effectiveness of Non-Pharmacological Interventions for Irritable Bowel Syndrome: A Systematic Review
por: Florent Amsallem, et al.
Publicado: (2021) -
Exploration of Ziziphi Spinosae Semen in Treating Insomnia Based on Network Pharmacology Strategy
por: Gong Feipeng, et al.
Publicado: (2021)